- Structure-based design of substituted hexafluoroisopropanol- arylsulfonamides as modulators of RORc
-
The structure-activity relationships of T0901317 analogs were explored as RORc inverse agonists using the principles of property- and structure-based drug design. An X-ray co-crystal structure of T0901317 and RORc was obtained and provided molecular insight into why T0901317 functioned as an inverse agonist of RORc; whereas, the same ligand functioned as an agonist of FXR, LXR, and PXR. The structural data was also used to design inhibitors with improved RORc biochemical and cellular activities. The improved inhibitors possessed enhanced selectivity profiles (rationalized using the X-ray crystallographic data) against other nuclear receptors.
- Fauber, Benjamin P.,De Leon Boenig, Gladys,Burton, Brenda,Eidenschenk, Celine,Everett, Christine,Gobbi, Alberto,Hymowitz, Sarah G.,Johnson, Adam R.,Liimatta, Marya,Lockey, Peter,Norman, Maxine,Ouyang, Wenjun,Rene, Olivier,Wong, Harvey
-
supporting information
p. 6604 - 6609
(2014/01/06)
-
- MODULATORS OF THE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTORS
-
The invention provides small molecule modulators of retinoic acid receptor-related orphan receptors such as RORα RORβ, or RORγ. Compounds of the invention can be effective modulators at concentrations ineffective to act on LXR receptors, or on other nuclear receptors, or other biological targets. Methods of modulation the RORs and methods of treating metabolic disorders, immune disorders, cancer, and CNS disorders wherein modulation of an ROR is medically indicated are also provided.
- -
-
Page/Page column 5; 87; 88
(2011/10/10)
-